RenalTransplant near Flushing, NY

Biography: Koji Takeda, MD, PhD is a cardiac surgeon and Surgical Director for Adult Heart Transplant at NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Takeda has a focus on heart failure, heart transplant surgery and mechanical circulatory support through ventricular assist devices (VADs). In addition to his clinical work, he is an active researcher in all of these areas, as well as in cardiac regeneration therapy. Dr. Takeda completed his medical training, post-graduate training, residency and fellowship in Osaka, Japan, after which he completed an advanced cardiovascular surgery fellowship at Northwestern University, Chicago. He is the recipient of multiple honors and awards including the American College of Chest Physicians Award, Japan Branch, 2009; and chief resident award and best resident award, 2005, at the National Cardiovascular Center, Osaka, Japan.

Biography: Dix P. Poppas, M.D., F.A.C.S., F.A.A.P. is Chief of Pediatric Urology at the Phyllis & David Komansky Children's Hospital of NewYork-Presbyterian Hospital - Weill Cornell Medical Center. He is the Richard Rodgers Professor of Pediatric Urology in the James Buchanan Brady Department of Urology at Weill Cornell Medicine. Dr. Poppas has been a tenured professor with Weill Cornell Medicine as of April 2006 and holds joint appointments as Professor of Pediatrics and Professor of Plastic and Reconstructive Surgery as well. His practice is limited to pediatric urology with special interest in genital reconstruction, laparoscopic and robotic surgery, intersex disorders and minimally invasive procedures for treating vesicoureteral reflux. Dr. Poppas has extensive experience in minimally invasive surgery and pediatric laparoscopy. He was chosen as one of the "Top One Hundred Minimally Invasive Surgeons in New York" and was the only pediatric urologist to be selected.His practice is limited to pediatric urology with special interest in genital reconstruction, laparoscopic and robotic surgery, surgical aspects of disorders of sexual development and minimally invasive procedures for treating vesicoureteral reflux. Dr. Poppas has extensive experience in minimally invasive surgery and pediatric laparoscopy. He was chosen as one of the "Top One Hundred Minimally Invasive Surgeons in New York" and was the only pediatric urologist to be selected and is listed as one of New York's Top Doctors and Best Doctors in America. He completed his residency in urology at New York Hospital-Cornell Medical School (1990-1994) and his fellowship in Pediatric Urology at Boston Children's Hospital-Harvard Medical School (1994-1996) He serves as co-director of the Laboratory for Minimally Invasive Urologic Surgery where his efforts are focused on developing advanced laparoscopic and Robotic surgical techniques for tissue reconstruction using novel tissue sealants to replace sutures and staples during surgery, as well as investigating the mechanisms and potential treatments for inhibiting and reversing fibrosis in the obstructed kidney using antibodies and gene therapy strategies. Dr. Poppas is a diplomate of The American Board of Urology, Fellow of the American Academy of Pediatrics and Fellow of the American College of Surgeons. He has been awarded The E. Darracott Vaughan Young Investigator Award by the National Kidney Foundation, The Edwin Beer Award of The New York Academy of Medicine, and was selected as an American Foundation for Urologic Disease/National Kidney Foundation Research Scholar. For more information: Minimal Access Surgery CenterEDUCATIONAL BACKGROUNDH.S. Diploma 1976J.R. Tucker High School, Richmond, V.A.1972-1976Longwood College, Farmville, VA.1978-1980B.S. Biology (Honors) 1982Minor ChemistryVirginia Commonwealth UniversityRichmond, VA 1980-1982Paramedic Degree 1984,Medical College of Virginia 1983-1984M.D. 1988, Eastern Virginia Medical School, Norfolk, VA., 1984-1988Non degree program Health Care Executive Management Program, Leonard Davis Institute of Health Economics, The Wharton School, University of PennsylvaniaCertificate of completion 2002Non degree program, Advanced Executive Management Program, Leonard Davis Institute of Health Economics, The Wharton School, University of PennsylvaniaCertificate of completion 2003Non degree program The Wharton Executive Management Program for Academic Surgery Leaders. Leonard Davis Institute of Health Care Economics, The Wharton School, University of PennsylvaniaCertificate of completion 2005PROFESSIONAL POSITIONS AND EMPLOYMENTIntern in General SurgeryEastern Virginia Graduate School of MedicineNorfolk, VA 7/88 to 6/89Resident in General SurgeryEastern Virginia Graduate School of Medicine, Norfolk, VA 7/89 to 6/90Assistant Urologist (Resident) New York Hospital, New York, NY 7/90 to 6/93Urologist(Chief Resident)New York Hospital, New York, NY 7/93 to 6/94Fellow-in-Pediatric Urology (Surgery)Children#146;s Hospital-Harvard Medical School 7/94 to 6/96Academic positions (teaching and research)Visiting Fellow in UrologyCornell University Medical Center, New York 7/94 to 6/96Assistant Professor of UrologyCornell University Medical Center, New York 7/96 to 11/01The Richard Rodgers Family Assistant Professor of Pediatric UrologyWeill Medical College of Cornell University, New York, NY 1/97 to 11/01Assistant Professor of Urology in Surgery (Plastic and Reconstructive Surgery)Weill Medical College of Cornell University, New York, NY 10/97 to 6/04Assistant Professor of Urology in Pediatrics (Department of Pediatrics)Weill Medical College of Cornell University, New York, NY 4/99 to 11/01Associate Professor of UrologyWeill Medical College of Cornell University, New York, NY 12/01 to presentAssociate Professor of Urology in Pediatrics (Department of Pediatrics)Weill Medical College of Cornell University, New York, NY 12/01 to presentThe Richard Rodgers Family Associate Professor of Pediatric UrologyWeill Medical College of Cornell University, New York, NY 12/01 to presentAssociate Professor of Urology in Surgery (Plastic and Reconstructive Surgery)Weill Medical College of Cornell University, New York, NY 7/04 to presentAssociate Professor of Urology in Obstetrics and Gynecology (Department of Obstetrics and Gynecology)Weill Medical College of Cornell UniversityNew York, NY 7/04 to presentHospital PositionsAssistant Attending UrologistNew York Presbyterian Hospital 7/96 to 11/01Associate Attending UrologistNew York Presbyterian Hospital 12/01 to presentAttending in SurgeryThe New York Hospital Medical Center of Queens 1/02 to presentEmployment (other than positions listed above)Clinical Consultant Promethean Surgical Devices, LLC, Woburn, MA. 6/00 to presentPROFESSIONAL MEMBERSHIPS (medical and scientific societies)Member Alpha Omega Alpha Honor Medical Society 1988 to presentMember American Urologic Association 1990 to presentFellow American Society for Laser Medicine and Surgery 1989 to 2001Fellow American College of Surgeons 1998 to presentMember Sigma Xi Scientific Research Society 1990 to presentMember The New York Section American Urological Association 1996 to presentMember Society for Pediatric Urology 1996 to presentMember The Hellenic Medical Society of New York 1996 to presentMember Society for Fetal Urology 1997 to presentMember The New York Clinical Society 1998 to presentFellow American Academy of Pediatrics 1998 to presentDiplomat American Board of Urology 1999 to present

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Care Philosophy: I strive to help patients treat the entire spectrum of their disease. We have direct contacts with multiple specialties to help patients get urgent appointments with other specialists if needed. We also have lists of support groups for those patients that need them

Biography: Dr. Emond is the Vice Chairman of Surgery at Columbia University. He has over 30 years of experience performing liver transplantation and complex liver and biliary surgery in children and adults, including the first living donor liver transplantation (LDLT) in the United States. Dr. Emond has published extensively in this field and was the co-chair of the NIH A2ALL program for 13 years. In collaboration with the department of Medicine at Columbia, Dr. Emond recruited the leadership of the Columbia Center for Translational immunology that created the foundation for translational and clinical research in transplantation tolerance. This will lead the way to inducing transplant tolerance in liver patients with the mixed chimerism strategy. As Director of Transplantation at the Columbia University Medical Center Dr. Emond's activities foster clinical excellence and research across all 11 of the solid organ transplant programs at the Medical Center. In recognition of his national and international leadership in transplantation, Dr. Emond is the past president of the American Society of Transplant Surgeons, the pre-eminent association of a transplant surgery. Contribution to Science Living donor liver transplantation Dr. Emond has spent a substantial portion of his career developing living donor liver transplantation and studying the safety of the procedure in both the donor and recipient. He participated in the first living donor liver transplant in the United States and focused on refining the techniques of performing living donor liver transplants and split liver transplants. He was the national co-chair of the NIH-sponsored Adult-to-Adult Living Donor Liver Transplantation (A2ALL) consortium from 2002 to 2015 to study the safety and outcomes of living donor liver transplants. Hepatic resection/ischemia Dr. Emond developed techniques for surgical resection of liver tumors and studied the effect of ischemia during resection on postoperative liver function. These studies include the outcomes of the extent of hepatectomy, the biochemical response to major hepatectomy and ischemia-reperfusion injury of the liver in rodent models. He has studied the clinical safety of inducing total vascular exclusion to provide a bloodless field during the liver transection. This has applications in both liver cancer and living donor hepatectomies. Hepatocellular carcinoma treatment Dr. Emond has studied many aspects of managing patients with hepatocellular carcinoma. These studies have included characterizing the risk factors for recurrence of disease following transplantation due to comorbidities and tumor characteristics. The research team has also studied the optimal method of preventing tumor growth in patients with HCC on the liver transplant wait list in addition to optimal strategies of liver allocation to optimize outcomes following liver transplantation. These studies have contributed to proposed changes in UNOS exception point allocation for liver transplant candidates with HCC. Pediatric liver transplantation Dr. Emond helped develop the field of pediatric liver transplantation. Contributions to this field include: the use of living donors for pediatric patients; use of auxiliary liver transplants for metabolic diseases; use of partial liver grafts for pediatric patients; and technical modifications that improved outcomes for this patient population. Visit The Center for Liver Disease and Transplantation at columbiasurgery.org/liver

Care Philosophy: Christopher S. Chandler, MD, values a patient-focused, multidisciplinary approach to achieve the optimal outcome for each patient. He uses leading technologies and techniques as he partners with a patient and their family to develop a treatment plan that meets their healthcare goals.